19701107

Source:http://linkedlifedata.com/resource/pubmed/id/19701107

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007131, umls-concept:C0030705, umls-concept:C0079083, umls-concept:C0144576, umls-concept:C0205179, umls-concept:C0205195, umls-concept:C0205390, umls-concept:C1708063, umls-concept:C2603343, umls-concept:C2827096
pubmed:issue	11
pubmed:dateCreated	2009-10-28
pubmed:abstractText	We aimed to evaluate the safety and efficacy of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy in patients with locally advanced or metastatic non-small cell lung cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101274235
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cytotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Glutathione, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/TER 286
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1556-1380
pubmed:author	pubmed-author:BellRobert BRB, pubmed-author:BocciaRalph VRV, pubmed-author:BrownGail LGL, pubmed-author:BurrisHoward AHA, pubmed-author:CaldwellDavid CDC, pubmed-author:EdelmanMartin JMJ, pubmed-author:EnglundCraig WCW, pubmed-author:FidiasPanos MPM, pubmed-author:HubermanMark SMS, pubmed-author:JonesMarshaM, pubmed-author:KeckJames GJG, pubmed-author:KolevskaTatjanaT, pubmed-author:LynchThomas JTJ, pubmed-author:MelnykOstapO, pubmed-author:MengLisaL, pubmed-author:MillsGlenn MGM, pubmed-author:RabinMichael SMS, pubmed-author:SequistLecia VLV, pubmed-author:TemelJennifer SJS
pubmed:issnType	Electronic
pubmed:volume	4
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1389-96
pubmed:meshHeading	pubmed-meshheading:19701107-Adult, pubmed-meshheading:19701107-Aged, pubmed-meshheading:19701107-Aged, 80 and over, pubmed-meshheading:19701107-Antineoplastic Agents, pubmed-meshheading:19701107-Carboplatin, pubmed-meshheading:19701107-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:19701107-Cytotoxins, pubmed-meshheading:19701107-Dose-Response Relationship, Drug, pubmed-meshheading:19701107-Drug Therapy, Combination, pubmed-meshheading:19701107-Female, pubmed-meshheading:19701107-Follow-Up Studies, pubmed-meshheading:19701107-Glutathione, pubmed-meshheading:19701107-Humans, pubmed-meshheading:19701107-Injections, Intravenous, pubmed-meshheading:19701107-Lung Neoplasms, pubmed-meshheading:19701107-Male, pubmed-meshheading:19701107-Middle Aged, pubmed-meshheading:19701107-Neoplasm Staging, pubmed-meshheading:19701107-Paclitaxel, pubmed-meshheading:19701107-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.
pubmed:affiliation	Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02114, USA. lvsequist@partners.org
pubmed:publicationType	Journal Article, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase II, Clinical Trial, Phase I